GlassScriptPhysician profile
John L Mikell
NPI 1023335726
$1,430.08
in general payments reported to CMS, 2019-2025
34 companies · $85.47 in 2025
The $85.47 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $10.18 · 2021: $15.00 · 2022: $395 · 2023: $294 · 2024: $499 · 2025: $85.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $193.09 | 2024 | |
| Novocure INC. | $119.51 | 2019 | |
| Merck Sharp & Dohme LLC | $110.78 | 2022-2025 | Keytruda, Welireg |
| Novartis Pharmaceuticals Corporation | $99.94 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $96.21 | 2023-2024 | Libtayo |
| Lilly USA, LLC | $83.00 | 2022-2024 | Verzenio, Retevmo, Jaypirca |
| Incyte Corporation | $75.20 | 2023-2024 | Jakafi, Monjuvi, Pemazyre |
| Genzyme Corporation | $73.10 | 2022-2023 | |
| Brainlab, INC. | $50.64 | 2024-2025 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning, Brainlab, INC. |
| Progenics Pharmaceuticals, INC. | $44.12 | 2023-2024 | Pylarify |
| Blue Earth Diagnostics | $38.89 | 2019-2022 | |
| Puma Biotechnology, INC. | $35.57 | 2022-2023 | |
| Pharmaessentia USA Corporation | $33.35 | 2022-2024 | Besremi |
| Astellas Pharma US INC | $25.59 | 2023 | Xospata |
| Eisai INC. | $24.29 | 2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $20.73 | 2023 | Givlaari |
| Jazz Pharmaceuticals INC. | $20.56 | 2022 | |
| Reflexion Medical, INC. | $20.38 | 2022 | |
| Boston Scientific Corporation | $20.21 | 2023 | Spaceoar Vue System - 10ml |
| Acrotech Biopharma INC. | $19.97 | 2022 | |
| Aveo Pharmaceuticals, INC. | $19.75 | 2022 | |
| Teleflex LLC | $19.70 | 2024 | |
| Adaptive Biotechnologies Corporation | $18.43 | 2023 | Clonoseq |
| Daiichi Sankyo INC. | $17.65 | 2022 | |
| Karyopharm Therapeutics INC. | $17.61 | 2023 | Xpovio |
| Bard Peripheral Vascular, INC. | $16.45 | 2022 | |
| Genmab U.S., INC. | $16.13 | 2023 | Epkinly |
| Hologic INC | $15.89 | 2022 | |
| Adc Therapeutics America, INC. | $15.38 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.00 | 2021 | |
| Alexion Pharmaceuticals, INC. | $14.87 | 2022 | |
| Genentech USA, INC. | $14.77 | 2022 | |
| Morphosys, US INC. | $13.14 | 2024 | Monjuvi |
| Focal Therapeutics, INC. | $10.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mikell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.